Ballentine Partners’s Mesoblast MESO Stock Holding History

Ballentine Partners’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	+10,448	New	+$155K	﹤0.01%	1035
2026 Q1	–	Sell	-11,136	Closed	-$201K	–	1064
2025 Q4	$201K	Sell	11,136 -394	-3%	-$6.78K	﹤0.01%	927
2025 Q3	$186K	Buy	11,530 +116	+1%	+$1.7K	﹤0.01%	933
2025 Q2	$124K	Buy	+11,414	New	+$128K	﹤0.01%	926
2025 Q1	–	Sell	-11,203	Closed	-$222K	–	971
2024 Q4	$222K	Buy	+11,203	New	+$124K	﹤0.01%	746

Other funds holding MESO

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Ballentine Partners's MESO Position: Q2 2026 in Review

Ballentine Partners opened a new position in Mesoblast (MESO) in Q2 2026: 10,448 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #1035 among its holdings. This is a return to the name: Ballentine Partners previously reported a position in MESO as recently as Q4 2025.

Ballentine Partners first reported a position in MESO in Q4 2024 and has held it in 5 quarters since. The position peaked at $222K in Q4 2024. 3 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

Ballentine Partners held 10,448 shares of Mesoblast worth $141K as of Q2 2026.
Mesoblast was a new Ballentine Partners position in Q2 2026.
Mesoblast made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1035 holding.
Ballentine Partners first reported a position in Mesoblast in Q4 2024 and has held it in 5 quarters since.
Ballentine Partners's Mesoblast position peaked at $222K in Q4 2024.
3 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.